Potential therapeutic mechanism of genistein in breast cancer involves inhibition of cell cycle regulation

Zhang,Ling; Yang,Bo; Zhou,Ke; Li,Hua; Li,Dong; Gao,Hui; Zhang,Tao; Wei,Dong; Li,Zhihui; Diao,Yong

doi:10.3892/mmr.2014.2907

Potential therapeutic mechanism of genistein in breast cancer involves inhibition of cell cycle regulation

Authors:
- Ling Zhang
- Bo Yang
- Ke Zhou
- Hua Li
- Dong Li
- Hui Gao
- Tao Zhang
- Dong Wei
- Zhihui Li
- Yong Diao
View Affiliations

Affiliations: Department of Radiotherapy, Chengdu Military General Hospital, Chengdu, Sichuan 610083, P.R. China, Department of Oncology, Chengdu Military General Hospital, Chengdu, Sichuan 610083, P.R. China, PET‑CT Center, Chengdu Military General Hospital, Chengdu, Sichuan 610083, P.R. China
Published online on: November 10, 2014 https://doi.org/10.3892/mmr.2014.2907
Pages: 1820-1826
Copyright: © Zhang et al. This is an open access article distributed under the terms of Creative Commons Attribution License [CC BY_NC 3.0].

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Genistein can prevent tumorigenesis and reduce the incidence of diseases that are dependent upon estrogen. Previous research, however, has shown that genistein can also increase the risk of breast cancer. Thus, the aim of the present study was to investigate the mechanism underlying the effect of genistein in breast cancer and to determine whether genistein produces a therapeutic effect or promotes the development of breast cancer. Gene microarray data obtained from three samples treated with alcohol (control group), three samples treated with 3 µmol/l genistein and three samples treated with 10 µmol/l genistein for 48 h, were downloaded from the Gene Expression Omnibus database. Analysis of the differentially expressed genes (DEGs) and functional enrichment in the two genistein groups was performed. The interaction networks of the DEGs were constructed and the overlapping network was extracted. Finally, the functions and pathways of the DEGs in the overlapping network were enriched. In total, 224 DEGs coexisted in the two genistein groups, and the most significant function of these was the cell cycle. The number and the fold change of expression values of the DEGs in the 10 µmol/l genistein group were significantly higher compared with that of the 3 µmol/l genistein group. The most significant function and pathway of the DEGs in the overlapping network was the cell cycle involving several genes, including GLIPR1, CDC20, BUB1, MCM2 and CCNB1. Thus, genistein stimulation resulted in gene expression changes in breast cancer cell lines and discrepancies increased with higher doses of genistein. The DEGs were most significantly associated with cell cycle regulation.

View Figures

View References

1	Jemal A, Siegel R, Xu J and Ward E: Cancer statistics, 2010. CA Cancer J Clin. 60:277–300. 2010. View Article : Google Scholar : PubMed/NCBI
2	Brenner H: Long-term survival rates of cancer patients achieved by the end of the 20th century: a period analysis. Lancet. 360:1131–1135. 2002. View Article : Google Scholar : PubMed/NCBI
3	Goldhirsch A, Glick JH, Gelber RD, Coates AS and Senn HJ: Meeting highlights: International consensus panel on the treatment of primary breast cancer. Seventh international conference on adjuvant therapy of primary breast cancer. J Clin Oncol. 19:3817–3827. 2001.PubMed/NCBI
4	Nathanson KL, Wooster R and Weber BL: Breast cancer genetics: what we know and what we need. Nat Med. 7:552–556. 2001. View Article : Google Scholar : PubMed/NCBI
5	Rahman N and Stratton MR: The genetics of breast cancer susceptibility. Annu Rev Genet. 32:95–121. 1998. View Article : Google Scholar
6	King MC, Marks JH and Mandell JB; New York Breast Cancer Study Group. Breast and ovarian cancer risks due to inherited mutations in BRCA1 and BRCA2. Science. 302:643–646. 2003. View Article : Google Scholar : PubMed/NCBI
7	Dixon RA and Ferreira D: Genistein. Phytochemistry. 60:205–211. 2002. View Article : Google Scholar : PubMed/NCBI
8	Marini H, Minutoli L, Polito F, et al: Effects of the phytoestrogen genistein on bone metabolism in osteopenic postmenopausal women: a randomized trial. Ann Intern Med. 146:839–847. 2007. View Article : Google Scholar : PubMed/NCBI
9	Fritz WA, Coward L, Wang J and Lamartiniere CA: Dietary genistein: perinatal mammary cancer prevention, bioavailability and toxicity testing in the rat. Carcinogenesis. 19:2151–2158. 1998. View Article : Google Scholar
10	Lamartiniere CA: Protection against breast cancer with genistein: a component of soy. Am J Clin Nutr. 71(Suppl): 1705S–1709S. 2000.PubMed/NCBI
11	Hsieh CY, Santell RC, Haslam SZ and Helferich WG: Estrogenic effects of genistein on the growth of estrogen receptor-positive human breast cancer (MCF-7) cells in vitro and in vivo. Cancer Res. 58:3833–3838. 1998.PubMed/NCBI
12	Messina MJ and Loprinzi CL: Soy for breast cancer survivors: a critical review of the literature. J Nutr. 131(Suppl): 3095S–3108S. 2001.PubMed/NCBI
13	Ju YH, Allred CD, Allred KF, Karko KL, Doerge DR and Helferich WG: Physiological concentrations of dietary genistein dose-dependently stimulate growth of estrogen-dependent human breast cancer (MCF-7) tumors implanted in athymic nude mice. J Nutr. 131:2957–2962. 2001.PubMed/NCBI
14	Shioda T, Chesnes J, Coser KR, et al: Importance of dosage standardization for interpreting transcriptomal signature profiles: evidence from studies of xenoestrogens. Proc Natl Acad Sci USA. 103:12033–12038. 2006. View Article : Google Scholar : PubMed/NCBI
15	Fujita A, Sato J, de Rodrigues LO, Ferreira CE and Sogayar MC: Evaluating different methods of microarray data normalization. BMC Bioinformatics. 7:4692006. View Article : Google Scholar : PubMed/NCBI
16	Troyanskaya O, Cantor M, Sherlock G, et al: Missing value estimation methods for DNA microarrays. Bioinformatics. 17:520–525. 2001. View Article : Google Scholar : PubMed/NCBI
17	Smyth GK: Limma: linear models for microarray data. Bioinformatics and Computational Biology Solutions Using R and Bioconductor. Gentleman R, Carey V, Dudoit S, Irizarry R and Huber W: Springer; New York, NY: pp. 397–420. 2005, View Article : Google Scholar
18	Tatusov RL, Natale DA, Garkavtsev IV, et al: The COG database: new developments in phylogenetic classification of proteins from complete genomes. Nucleic Acids Res. 29:22–28. 2001. View Article : Google Scholar :
19	Altschul SF, Gish W, Miller W, Myers EW and Lipman DJ: Basic local alignment search tool. J Mol Biol. 215:403–410. 1990. View Article : Google Scholar : PubMed/NCBI
20	Giot L, Bader JS, Brouwer C, et al: A protein interaction map of Drosophila melanogaster. Science. 302:1727–1736. 2003. View Article : Google Scholar : PubMed/NCBI
21	Deng M, Zhao JY, Ju XD, Tu PF, Jiang Y and Li ZB: Protective effect of tubuloside B on TNFalpha-induced apoptosis in neuronal cells. Acta Pharmacol Sin. 25:1276–1284. 2004.PubMed/NCBI
22	Breitkreutz B-J, Stark C and Tyers M: Osprey: a network visualization system. Genome Biol. 4:R222003. View Article : Google Scholar : PubMed/NCBI
23	Willis RC and Hogue CW: Searching, viewing, and visualizing data in the Biomolecular Interaction Network Database (BIND). Curr Protoc Bioinformatics. Chapter 8(Unit 8): 92006.
24	Breitkreutz BJ, Stark C and Tyers M: The GRID: the General Repository for Interaction Datasets. Genome Biol. 4:R232003. View Article : Google Scholar : PubMed/NCBI
25	Nam D and Kim SY: Gene-set approach for expression pattern analysis. Brief Bioinform. 9:189–197. 2008. View Article : Google Scholar : PubMed/NCBI
26	Huang da W, Sherman BT and Lempicki RA: Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc. 4:44–57. 2009. View Article : Google Scholar : PubMed/NCBI
27	Zhang B, Kirov S and Snoddy J: WebGestalt: an integrated system for exploring gene sets in various biological contexts. Nucleic Acids Res. 33:W741–W748. 2005. View Article : Google Scholar : PubMed/NCBI
28	Duncan D, Prodduturi N and Zhang B: WebGestalt2: an updated and expanded version of the Web-based Gene Set Analysis Toolkit. BMC Bioinformatics. 11:P102010. View Article : Google Scholar
29	Coles C, Condie A, Chetty U, Steel CM, Evans HJ and Prosser J: p53 mutations in breast cancer. Cancer Res. 52:5291–5298. 1992.PubMed/NCBI
30	Giancotti V: Breast cancer markers. Cancer Lett. 243:145–159. 2006. View Article : Google Scholar : PubMed/NCBI
31	Ganz PA: Breast cancer, menopause, and long-term survivorship: critical issues for the 21st century. Am J Med. 118:136–141. 2005. View Article : Google Scholar
32	Yu H: Cdc20: A WD40 activator for a cell cycle degradation machine. Mol Cell. 27:3–16. 2007. View Article : Google Scholar : PubMed/NCBI
33	Yuan B, Xu Y, Woo JH, et al: Increased expression of mitotic checkpoint genes in breast cancer cells with chromosomal instability. Clin Cancer Res. 12:405–410. 2006. View Article : Google Scholar : PubMed/NCBI
34	Agarwal R, Gonzalez-Angulo AM, Myhre S, et al: Integrative analysis of cyclin protein levels identifies cyclin b1 as a classifier and predictor of outcomes in breast cancer. Clin Cancer Res. 15:3654–3662. 2009. View Article : Google Scholar : PubMed/NCBI
35	Gonzalez MA, Pinder SE, Callagy G, et al: Minichromosome maintenance protein 2 is a strong independent prognostic marker in breast cancer. J Clin Oncol. 21:4306–4313. 2003. View Article : Google Scholar : PubMed/NCBI
36	Yang J, Ramnath N, Moysich KB, et al: Prognostic significance of MCM2, Ki-67 and gelsolin in non-small cell lung cancer. BMC Cancer. 6:2032006. View Article : Google Scholar : PubMed/NCBI
37	Sotiriou C, Neo SY, McShane LM, et al: Breast cancer classification and prognosis based on gene expression profiles from a population-based study. Proc Natl Acad Sci USA. 100:10393–10398. 2003. View Article : Google Scholar : PubMed/NCBI
38	Cappelletti V, Fioravanti L, Miodini P and Di Fronzo G: Genistein blocks breast cancer cells in the G(2)M phase of the cell cycle. J Cell Biochem. 79:594–600. 2000. View Article : Google Scholar : PubMed/NCBI
39	Fioravanti L, Cappelletti V, Miodini P, Ronchi E, Brivio M and Di Fronzo G: Genistein in the control of breast cancer cell growth: insights into the mechanism of action in vitro. Cancer Lett. 130:143–152. 1998. View Article : Google Scholar : PubMed/NCBI
40	Li Y, Upadhyay S, Bhuiyan M and Sarkar FH: Induction of apoptosis in breast cancer cells MDA-MB-231 by genistein. Oncogene. 18:3166–3172. 1999. View Article : Google Scholar : PubMed/NCBI
41	Salomons GS, Brady HJ, Verwijs-Janssen M, et al: The Bax alpha:Bcl-2 ratio modulates the response to dexamethasone in leukaemic cells and is highly variable in childhood acute leukaemia. Int J Cancer. 71:959–965. 1997. View Article : Google Scholar : PubMed/NCBI
42	Ren C, Li L, Yang G, et al: RTVP-1, a tumor suppressor inactivated by methylation in prostate cancer. Cancer Res. 64:969–976. 2004. View Article : Google Scholar : PubMed/NCBI